Today, the CEO & COB of Inovalon (NASDAQ: INOV), Keith Dunleavy, bought shares of INOV for $1.17M.
Following this transaction Keith Dunleavy’s holding in the company was increased by 58.78% to a total of $3.88 million.
See today’s analyst top recommended stocks >>
INOV’s market cap is $1.4B and the company has a P/E ratio of 97. Currently, Inovalon has an average volume of 847.1K.
Six different firms, including Goldman Sachs and KeyBanc, currently also have a Buy rating on the stock. Based on 3 analyst ratings, the analyst consensus is Moderate Sell with an average price target of $10.50, reflecting a -5.7% downside.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded on September 11, 2014 and is headquartered in Bowie, MD.
